Steve Davidson

Dr. Steve Davidson

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in eLife
Verified
Journal Article
Open access
MNMinh Q Nguyen
Minh Q Nguyen
LBLars J von Buchholtz
Lars J von Buchholtz
ARAshlie N Reker
Ashlie N Reker
NRNicholas Jp Ryba
Nicholas Jp Ryba
SDSteve Davidson
Steve Davidson
Somatosensory neurons with cell bodies in the dorsal root ganglia (DRG) project to the skin, muscles, bones, and viscera to detect touch and temperature as well as to mediate proprioception and many types of interoception. In addition, the somatosensory system conveys the clinically relevant noxious sensations of pain and itch. Here, we used single nuclear transcriptomics to characterize transcriptomic classes of human DRG neurons that detect these diverse types of stimuli. Notably, multiple types of human DRG neurons have transcriptomic features that resemble their mouse counterparts although expression of genes considered important for sensory function often differed between species. More unexpectedly, we identified several transcriptomic classes with no clear equivalent in the other species. This dataset should serve as a valuable resource for the community, for example as means of focusing translational efforts on molecules with conserved expression across species.

8 September 2016 in Nature Protocols
Verified
Journal Article
Closed access
MVManouela V Valtcheva
Manouela V Valtcheva
BCBryan A Copits
Bryan A Copits
SDSteve Davidson
Steve Davidson
TSTayler D Sheahan
Tayler D Sheahan
MPMelanie Y Pullen
Melanie Y Pullen
RGRobert W Gereau
Robert W Gereau

1 July 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SDShibin Du
Shibin Du
SWShaogen Wu
Shaogen Wu
XFXiaozhou Feng
Xiaozhou Feng
BWBing Wang
Bing Wang
SXShangzhou Xia
Shangzhou Xia
YTYuan-Xiang Tao
Yuan-Xiang Tao
Maladaptive changes of nerve injury–associated genes in dorsal root ganglia (DRGs) are critical for neuropathic pain genesis. Emerging evidence supports the role of long noncoding RNAs (lncRNAs) in regulating gene transcription. Here we identified a conserved lncRNA, named nerve injury–specific lncRNA (NIS-lncRNA) for its upregulation in injured DRGs exclusively in response to nerve injury. This upregulation was triggered by nerve injury–induced increase in DRG ELF1, a transcription factor that bound to the NIS-lncRNA promoter. Blocking this upregulation attenuated nerve injury–induced CCL2 increase in injured DRGs and nociceptive hypersensitivity during the development and maintenance periods of neuropathic pain. Mimicking NIS-lncRNA upregulation elevated CCL2 expression, increased CCL2-mediated excitability in DRG neurons, and produced neuropathic pain symptoms. Mechanistically, NIS-lncRNA recruited more binding of the RNA-interacting protein FUS to the Ccl2 promoter and augmented Ccl2 transcription in injured DRGs. Thus, NIS-lncRNA participates in neuropathic pain likely by promoting FUS-triggered DRG Ccl2 expression and may be a potential target in neuropathic pain management.

1 May 2021 in Neuron
Verified
Journal Article
Closed access
WRWilliam Renthal
William Renthal
ACAlexander Chamessian
Alexander Chamessian
MCMichele Curatolo
Michele Curatolo
SDSteve Davidson
Steve Davidson
Michael D. BurtonMichael D. Burton
Michael D. Burton
TPTheodore J. Price
Theodore J. Price

26 November 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CPChloe J. Peach
Chloe J. Peach
RTRaquel Tonello
Raquel Tonello
EDElisa Damo
Elisa Damo
KGKimberly Gomez
Kimberly Gomez
ACAida Calderon-Rivera
Aida Calderon-Rivera
NBNigel W. Bunnett
Nigel W. Bunnett
Nerve growth factor (NGF) monoclonal antibodies inhibit chronic pain, yet failed to gain approval due to worsened joint damage in osteoarthritis patients. We report that neuropilin-1 (NRP1) is a coreceptor for NGF and tropomyosin-related kinase A (TrkA) pain signaling. NRP1 was coexpressed with TrkA in human and mouse nociceptors. NRP1 inhibitors suppressed NGF-stimulated excitation of human and mouse nociceptors and NGF-evoked nociception in mice. NRP1 knockdown inhibited NGF/TrkA signaling, whereas NRP1 overexpression enhanced signaling. NGF bound NRP1 with high affinity and interacted with and chaperoned TrkA from the biosynthetic pathway to the plasma membrane and endosomes, enhancing TrkA signaling. Molecular modeling suggested that the C-terminal R/KXXR/K NGF motif interacts with the extracellular “b” NRP1 domain within a plasma membrane NGF/TrkA/NRP1 of 2:2:2 stoichiometry. G α interacting protein C-terminus 1 (GIPC1), which scaffolds NRP1 and TrkA to myosin VI, colocalized in nociceptors with NRP1/TrkA. GIPC1 knockdown abrogated NGF-evoked excitation of nociceptors and pain-like behavior. Thus, NRP1 is a nociceptor-enriched coreceptor that facilitates NGF/TrkA pain signaling. NRP binds NGF and chaperones TrkA to the plasma membrane and signaling endosomes via the GIPC1 adaptor. NRP1 and GIPC1 antagonism in nociceptors offers a long-awaited nonopioid alternative to systemic antibody NGF sequestration for the treatment of chronic pain.

18 February 2020 in eneuro
Verified
Journal Article
Open access
PDF file
ARAshlie N. Reker
Ashlie N. Reker
SCSisi Chen
Sisi Chen
KEKatherine Etter
Katherine Etter
TBTaylor Burger
Taylor Burger
MCMakayla Caudill
Makayla Caudill
SDSteve Davidson
Steve Davidson
Pain is a multidimensional experience of sensory-discriminative, cognitive, and affective processes; however, current basic research methods rely heavily on response to threshold stimuli, bypassing the supraspinal processing that ultimately gives rise to the pain experience. We developed the operant plantar thermal assay (OPTA), which utilizes a novel, conflict-based operant task requiring evaluation and active decision-making to obtain reward under thermally aversive conditions to quantify thermal pain tolerance. In baseline measures, male and female mice exhibited similar temperature preferences, however in the OPTA, female mice exhibited greater temperature-dependent tolerance, as defined by choice time spent in an adverse thermal condition to obtain reward. Increasing reward salience (4% vs 10% sucrose solution) led to increased thermal tolerance for males but not females. To determine whether neuropathic and inflammatory pain models alter thermal tolerance, animals with chronic constriction injury (CCI) or complete Freund’s adjuvant (CFA), respectively, were tested in the OPTA. Surprisingly, neuropathic animals exhibited increased thermal tolerance, as shown by greater time spent in the reward zone in an adverse thermal condition, compared with sham animals. There was no effect of inflammation on thermal tolerance. Administration of clonidine in the CCI model led to increased thermal tolerance in both injured and sham animals. In contrast, the non-steroidal anti-inflammatory meloxicam was anti-hyperalgesic in the CFA model, but reduced thermal pain tolerance. These data support the feasibility of using the OPTA to assess thermal pain tolerance to gain new insights into complex pain behaviors and to investigate novel aspects of analgesic efficacy.